Neuspera Medical

Neuspera Medical, Inc. is a neuromodulation company developing the Neuspera Implantable Sacral Neuromodulation (SNM) System, a minimally invasive implant designed to treat urinary urge incontinence (UUI) and overactive bladder (OAB). The system offers patients personal control and relief from symptoms, aiming to improve their quality of life.

Funding Round: Series D

Funding Amount: $23M

Date: 15-Jul-2024

Investors: Vertex Ventures HC, Treo Ventures, Action Potential Venture Capital, Windham Venture Partners, Olympus Innovation Ventures, another strategic investor

Markets: Medtech, Neuromodulation, Medical Device

HQ: San Jose, California, United States

Founded: 2013

Website: https://www.neuspera.com/

LinkedIn: https://www.linkedin.com/company/neusperamedicalinc.

Twitter: https://twitter.com/neusperamedical

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/neuspera-medica

Pitchbook: https://pitchbook.com/profiles/company/158837-59